美国淋巴水肿治疗市场预测至2028年 - 按病情类型、治疗类型和终端用户的COVID-19影响和国家分析

美国淋巴水肿治疗市场规模预计将从2022年的51.8598亿美元增长到2028年的83.207亿美元；估计从2023年到2028年将录得8.2%的复合增长率。

美国淋巴水肿治疗市场的增长归功于淋巴水肿病例发病率的上升，以及医疗保健服务和淋巴水肿管理项目的增加。然而，缺乏意识和熟练的专业人员阻碍了市场的增长。

淋巴水肿是指淋巴液在皮肤下面的脂肪组织中的积聚。这种情况是由于一个人的淋巴系统流动受阻造成的，可以在腿部或手臂或两者中观察到。它也可能影响一个人的腹部、颈部、生殖器和面部，这取决于接受治疗的身体部位。原发性淋巴水肿一般在出生时就存在，而继发性淋巴水肿是由于淋巴系统功能失调或损坏造成的。

根据美国心脏病学院基金会的报告，淋巴水肿的治疗主要由症状管理、减少体积和预防感染来推动。例如，淋巴水肿的第一线治疗是保守治疗。完全减容疗法（CGT）已成为物理治疗性保守管理的前沿阵地。此外，外科治疗方法为保守治疗提供了良好的依从性。此外，用于治疗淋巴水肿的新的微创血管化淋巴结转移术已在世界范围内获得了极大的关注。例如，位于亚利桑那州凤凰城/斯科茨代尔的梅奥诊所园区的医生们已经开发出一种新的门诊手术，用于治疗对传统疗法不适用的淋巴水肿患者。与淋巴结转移相关的好处是大大减少了疼痛和淋巴解剖的肿胀。此外，该手术允许患者减少抗生素的使用，在患者群体中增加了生活质量的好处。此外，被诊断为乳腺癌、皮肤阴茎癌、膀胱癌和妇科癌症的患者可以接受淋巴结手术。

淋巴水肿是一种慢性的、无法治愈的疾病，影响着病人的身体和精神健康。事实证明，基于期限的护理是一种多学科的病人管理方法。定期护理团队包括来自物理康复、血管医学、整形外科、放射科、肿瘤科、传染病和社会工作的人员。该团队可以为评估肢体肿胀的病因提供全面的评估，优化保守护理，并为合适的人选提供手术治疗。

MedStar Health报告指出，患者的淋巴水肿治疗计划将取决于病因和病情的严重程度。医生可能会开药或转诊给专门管理淋巴水肿的物理或职业治疗师。疗法包括通过锻炼、特殊按摩技术或机械泵装置来减少肿胀和控制疼痛。如果病人的病情严重，医生可能会建议进行更先进的治疗，如淋巴结转移和淋巴管分流。

梅奥医学教育和研究基金会的报告指出，与以前使用的腹腔镜手术相比，机器人技术在淋巴手术中的效用使其具有更大的灵活性和精确性。此外，事实证明，使用机器人技术对外科医生和病人的效果都是最佳的，并将在预测期内显示出积极的结果。例如，2020年5月接受单机器人手术治疗淋巴水肿的患者提供了积极的传闻反馈，包括显著的临床改善，如能够穿上衣服，有了外科医生的重大成就。此外，启用人工智能（AI）的机器人正越来越多地协助淋巴水肿手术中的显微外科手术，以减少可能影响患者恢复的外科医生变化。例如，对于淋巴水肿手术，2020年5月，一名泌尿外科医生通过利用自由淋巴结转移，进行了首例单孔机器人精神收割，旨在对淋巴水肿进行微创手术治疗。这种新的手术治疗方法的主要目的是最大限度地减少供体部位的发病率与衰弱的淋巴水肿症状。

基于治疗的见解

根据治疗方法，美国淋巴水肿治疗市场被分为激光治疗、压缩设备和绷带、药物治疗、生理程序、切除程序及其他。生理程序部分被进一步细分为淋巴管吻合术（LVA）和血管化淋巴结转移术（VLNT）。同样，切除程序部分又被细分为手术切除、吸脂和其他。2022年，压缩设备和绷带部分占据了市场的最大份额。在预测期内，生理程序部分预计将录得最高的复合年增长率，主要是由于通过对淋巴水肿患者进行的LVA和VLNT治疗的可用性。目前有两种主要的生理干预措施被纳入治疗淋巴水肿。主要的干预措施是在靠近淋巴阻塞的位置，在充血的淋巴通道与静脉系统之间建立一个分流（一个孔或一个小通道，以方便移动）。另一种生理干预措施是结合血管化软组织瓣，其中经常包括受影响的淋巴结的血管化淋巴结。在这部分中，血管化淋巴结转移（VLNT）手术在预测年内将以最高的年复合增长率%增长。北美放射学会（RSNA）指出，淋巴水肿的治疗在传统上是保守的和有限的，但如今手术和显微外科手术已经大大增加了。例如，VLNT是微型手术中最突出和最有前途的技术之一。VLNT涉及将功能淋巴结（LNs）从健康的供体部位转移到身体中淋巴引流受损或病变的区域。

目录

第一章：简介

• 本研究的范围
• Insight Partners的研究报告指导
• 市场细分
  • 全球临床试验成像市场 - 按模式划分
  • 全球临床试验成像市场 - 按产品分类
  • 全球临床试验成像市场 - 按终端用户划分
  • 全球临床试验成像市场 - 按地理区域划分

第二章：临床试验成像市场 - 主要结论

第三章：研究方法

• 覆盖面
• 二级研究
• 初级研究

第四章：临床试验成像市场 - 市场格局

• 市场概况
• PEST分析
  • 北美洲PEST分析
  • 欧洲PEST分析
  • 亚太地区PEST分析
  • 中东和非洲PEST分析
  • 南美和中美洲PEST分析
• 专家意见

第五章：临床试验成像市场 - 主要市场动态

• 市场驱动力
  • 制药和生物技术行业的临床试验活动加速发展
  • 提供医学影像服务的CRO数量激增
• 市场限制因素
  • 高投资和标准化的基础设施要求
• 市场机会
  • 线性成像临床试验
• 未来趋势
  • 人工智能驱动的临床试验
• 影响分析

第六章：临床试验成像市场 - 全球分析

• 全球临床试验成像市场收入预测和分析
• 按地理区域分類的全球临床试验成像市场 - 预测与分析
• 主要参与者的市场定位

第七章 ：2028年临床试验成像市场收入和预测 - 按模式划分

• 概述
• 按模式划分，临床试验成像市场收入份额（2022年和2028年）
• 断层扫描
• 超声波
• 正电子发射断层扫描
• X-射线
• 超声心动图
• 磁共振成像
• 其他

第八章：2028年临床试验成像市场收入和预测 - 提供服务

• 概述
• 临床试验成像市场收入份额，按服务项目划分（2022年和2028年）
• 试验设计咨询服务
  • 概述
• 阅读分析服务
  • 概述
• 操作成像服务
  • 医学影像服务简介
• 成像软件
  • 纵览
• 其他
  • 概述

第九章：2028年临床试验成像市场收入和预测 - 按终端用户划分

• 概述
• 临床试验成像市场收入份额，按终端用户划分（2022年和2028年）
• 制药和生物制药公司
• 合同研究组织
• 学术和研究机构
• 其他

第十章：临床试验成像市场 - 2028年的收入和预测 - 地域分析

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚
  • 亚太其他地区
• 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美和中美洲其他地区
• 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿拉伯联合酋长国
  • 中东和非洲其他地区

第十一章：COVID-19大流行对临床试验成像市场的影响

• 北美洲：对COVID-19大流行的评估
• 欧洲
• 亚太地区
• 南美洲和中美洲
• 中东和非洲

第十二章 ：临床试验成像市场 - 行业格局

• 概述
• 临床试验成像市场的增长策略
• 无机增长战略
  • 概述
• 有机增长策略
  • 综述

第十三章 ：公司简介

• eResearch Technology Inc
• Calyx Inc
• ICON PLC
• VIDA Diagnostics Inc
• WCG Clinical Inc
• BioTelemetry Inc
• Medical Metrics Inc
• Medpace Holdings Inc
• Radiant Sage LLC
• IXICO plc

第十四章：附录

• 关于洞察力合作伙伴
• 术语表

The US lymphedema treatment market size is expected to grow from US$ 5,185.98 million in 2022 to US$ 8,320.07 million by 2028; it is estimated to record a CAGR of 8.2% from 2023 to 2028.

The US lymphedema treatment market growth is attributed to the rising incidence of lymphedema cases and increasing healthcare services and lymphedema management programs. However, a lack of awareness and skilled proffesionals is hampering the growth of the market.

Lymphedema involve the accumulation of lymph fluid in fatty tissues just beneath the skin. The condition is caused due to impaired flow in the lymphatic system of a person and is observed either in the legs or arms or in both. It can also be affecting abdomen, neck, genitals, and face of a person, depending on the portion of the body which has undergone treatment. Primary lymphedema is generally present at birth, while secondary lymphedema is caused due to dysfunction or damage to the lymphatic system.

According to the American College of Cardiology Foundation report, the treatment of lymphedema is primarily driven by symptom management, volume reduction, and infection prevention. For example, the first line of treatment for lymphedema is conservative management. Complete decongestive therapy (CGT) has become the forefront of physiotherapeutic conservative management. Additionally, surgical treatment approaches provide good adherence to conservative management. Moreover, the new minimally invasive vascularized lymph node transfer for lymphedema has gained significant attention worldwide. For example, physicians at Mayo Clinic's campus in Phoenix/Scottsdale, Arizona, have developed a new outpatient surgical procedure for patients experiencing lymphedema refractory to traditional therapy. Benefits associated with lymph node transfer involve a significant reduction of pain and swelling in the lymphedemic anatomy. Also, the surgery allows patients to decrease their antibiotic use, adding quality-of-life benefits among the patient pool. Further, patients diagnosed with breast, skin penile, bladder, and gynecological cancers may undergo lymph nodes procedure.

Lymphedema is a chronic, incurable disease affecting a patient's physical and mental well-being. Term-based care proves to be a multidisciplinary approach for patient management. The term-based care team includes people from physical rehabilitation, vascular medicine, plastic surgery, radiology, oncology, infectious disease, and social work. The team can provide a thorough evaluation for assessing the etiology of limb swelling, optimizing conservative care, and offering surgical treatment for appropriate candidates.

MedStar Health report states that a patient's lymphedema treatment plans will depend on the cause and severity of the condition. Doctors may prescribe medication or refer to a physical or occupational therapist specializing in the management of lymphedema. Therapies include reducing swelling and controlling pain through exercises, special massage techniques, or mechanical pumping devices. If a patient's condition is severe, doctors may recommend more advanced treatments such as lymph node transfer and lymphovenous bypass.

The Mayo Foundation for Medical Education and Research report states that the utility of robotics for lymphatic surgery allows much greater flexibility and precision compared to previously used laparoscopy. Additionally, the use of robotics proves optimal for both surgeon and patient outcomes and will reveal positive results during the forecast period. For instance, patients who underwent single-robotic surgery for lymphedema in May 2020 have provided positive anecdotal feedback, including significant clinical improvement such as the ability to wear clothes with the surgeon's significant accomplishments. Further, robots enabled with artificial intelligence (AI) are increasingly assisting in microsurgical procedures in lymphedema surgeries for reducing surgeon variations that could affect patient recovery. For example, for lymphedema surgery, in May 2020, an urogynecology surgeon performed a first-of-its-kind single-port robotic mental harvest by utilizing a free lymph node transfer, intended for minimally invasive surgical treatment of lymphedema. The main objective of this new surgical treatment method is to minimize donor site morbidity with debilitating lymphedema symptoms.

Treatment-Based Insights

Based on treatment, the US lymphedema treatment market is categorized into laser therapy, compression devices and bandaging, drug therapy, physiological procedures, debulking procedures, and others. The physiological procedures segment is further segmented into lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT). Similarly, the debulking procedures segment is subdivided into surgical debulking, liposuction, and others. The compression devices and bandaging segment held the largest share of the market in 2022. The physiological procedure segment is anticipated to register the highest CAGR during the forecast period mainly due to the treatment availability through LVA and VLNT performed on lymphedema patients. Two main physiologic interventions are currently incorporated to treat lymphedema. The primary intervention creates a shunt (a hole or a small passage to facilitate movement) between the congested lymphatic channels with the venous system close to the location of lymphatic obstruction. The other physiologic intervention incorporates vascularized soft tissue flaps that frequently include vascularized lymph nodes to the affected lymphatic extremity. Under this segment, the vascularized lymph node transfer (VLNT) procedure will grow at the highest CAGR% during the forecasted year. The Radiological Society of North America (RSNA) states that lymphedema treatment has traditionally been conservative and limited, but surgical and microsurgical procedures have risen tremendously today. For instance, VLNT is one of the most prominent and promising techniques for micro surgeries. VLNT involves the transfer of functional lymph nodes (LNs) from a healthy donor site to an area of the body with damaged or diseased lymphatic drainage.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US lymphedema treatment market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the US lymphedema treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

2. US Lymphedema Treatment Market – Key Takeaways

3. Research Methodology

• 3.1 Coverage 24
• 3.2 Secondary Research
• 3.3 Primary Research

4. Lymphedema Treatment Market – Market Landscape

• 4.1 Overview
• 4.2 Experts' Opinion

5. Lymphedema Treatment Market – Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Rising Incidence of Lymphedema Cases
  • 5.1.2 Increasing Healthcare Services and Lymphedema Management Programs
• 5.2 Market Restraints
  • 5.2.1 Lack of Awareness and Skilled Professionals
• 5.3 Market Opportunities
  • 5.3.1 Rising Treatment Options
• 5.4 Future Trends
  • 5.4.1 Use of Robotics for Lymphedema Treatment
• 5.5 Impact Analysis

6. US Lymphedema Treatment Market Analysis

• 6.1 US Lymphedema Treatment Market Revenue Forecast and Analysis
• 6.2 US Lymphedema Treatment Market, By Company Products

7. US Lymphedema Treatment Market Analysis – by Condition Type

• 7.1 Overview
• 7.2 Primary Lymphedema
• 7.3 Secondary Lymphedema

8. US Lymphedema Treatment Market Analysis – by Treatment Type

• 8.1 Overview
• 8.2 Laser Therapy
• 8.3 Compression Devices and Bandaging
• 8.4 Drug Therapy
• 8.5 Physiological Procedures
• 8.6 Debulking Procedures
• 8.7 Others

9. US Lymphedema Treatment Market Analysis – by End User

• 9.1 Overview
• 9.2 Hospitals
• 9.3 Clinics
• 9.4 Clinical Research Organization
• 9.5 Others

10. US Lymphedema Treatment Market

• 10.1 Overview
  • 10.1.1 US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1 US Lymphedema Treatment Market, by Condition Type, 2019–2028 (USD Million)
    • 10.1.1.2 US Lymphedema Treatment Market, by Treatment Type, 2019–2028 (USD Million)
    • 10.1.1.3 US Lymphedema Treatment Market, by End User, 2019–2028 (USD Million)

11. US Lymphedema Treatment Market: Impact Assessment of COVID-19 Pandemic

• 11.1 Impact Analysis of COVID-19 Pandemic on US Lymphedema Treatment Market

12. US Lymphedema Treatment Market–Industry Landscape

• 12.1 Overview
• 12.2 Organic Developments

13. Company Profiles

• 13.1 BIOCOMPRESSION SYSTEMS
• 13.2 Tactile Medical
• 13.3 Essity AB
• 13.4 Lohmann & Rauscher GmbH & Co. KG
• 13.5 SIGVARIS GROUP
• 13.6 ThermoTek Inc
• 13.7 Huntleigh Healthcare Limited
• 13.8 3M Co
• 13.9 AIROS Medical
• 13.10 PAUL HARTMANN AG

14. Appendix

• 14.1 About The Insight Partners
• 14.2 Glossary of Terms

List Of Tables

• Table 1. North America Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 2. North America Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 3. North America Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 4. US Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 5. US Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 6. US Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 7. Canada: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 8. Canada: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 9. Canada: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 10. Mexico: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 11. Mexico: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 12. Mexico: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 13. Europe Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 14. Europe Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 15. Europe Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 16. Germany: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 17. Germany: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 18. Germany: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 19. UK Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 20. UK Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 21. UK Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 22. France: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 23. France: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 24. France: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 25. Italy: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 26. Italy: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 27. Italy: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 28. Spain: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 29. Spain: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 30. Spain: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 31. Rest of Europe: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 32. Rest of Europe: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 33. Rest of Europe: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 34. Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 35. Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 36. Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 37. China Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 38. China Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 39. China Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 40. Japan Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 41. Japan Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 42. Japan Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 43. India Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 44. India Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 45. India Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 46. South Korea Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 47. South Korea Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 48. South Korea Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 49. Australia Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 50. Australia Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 51. Australia Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 52. Rest of Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 53. Rest of Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 54. Rest of Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 55. South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 56. South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 57. South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 58. Brazil Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 59. Brazil Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 60. Brazil Clinical Trial Imaging Market, by End Use- Revenue and Forecast to 2028 (US$ Million)
• Table 61. Argentina Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 62. Argentina Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 63. Argentina Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 64. Rest of South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 65. Rest of South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
• Table 66. Rest of South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
• Table 67. Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 68. Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 69. Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 70. South Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 71. South Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 72. South Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 73. Saudi Arabia Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 74. Saudi Arabia Clinical Trial Imaging Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
• Table 75. Saudi Arabia Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 76. UAE Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 77. UAE Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 78. UAE Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 79. Rest of Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 80. Rest of Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
• Table 81. Rest of Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 82. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
• Table 83. Recent Organic Growth Strategies in Clinical Trial Imaging Market
• Table 84. Glossary of Terms

List Of Figures

• Figure 1. Clinical Trial Imaging Market Segmentation
• Figure 2. Clinical Trial Imaging Market by Region
• Figure 3. Global Clinical Trial Imaging Market Overview
• Figure 4. Tomography Largest Share of Modality Segment in Clinical Trial Imaging Market
• Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
• Figure 6. Clinical Trial Imaging Market, by Geography (US$ Million)
• Figure 7. Global Clinical Trial Imaging Market - Leading Country Markets (US$ Million)
• Figure 8. Global Clinical Trial Imaging Market - Industry Landscape
• Figure 9. North America: PEST Analysis
• Figure 10. Europe: PEST Analysis
• Figure 11. Asia Pacific: PEST Analysis
• Figure 12. Middle East and Africa: PEST Analysis
• Figure 13. South and Central America: PEST Analysis
• Figure 14. Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
• Figure 15. Global Clinical Trial Imaging Market - Revenue Forecast and Analysis - 2021-2028
• Figure 16. Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis (2022-2028)
• Figure 17. Market Positioning of Key Players in the Clinical Trial Imaging Market
• Figure 18. Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
• Figure 19. Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 20. Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 21. PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 22. X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 23. Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 24. Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 25. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 26. Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
• Figure 27. Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 28. Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 29. Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 30. Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 31. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 32. Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
• Figure 33. Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 34. Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 35. Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 36. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 37. North America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 38. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 39. North America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
• Figure 40. US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 41. Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 42. Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 43. Europe: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 44. Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 45. Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
• Figure 46. Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 47. UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 48. France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 49. Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 50. Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 51. Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 52. Asia Pacific: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 53. Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 54. China Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 55. Japan Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 56. India Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 57. South Korea Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 58. Australia Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 59. Rest of Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 60. South and Central America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 61. South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 62. Brazil Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 63. Argentina Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 64. Rest of South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
• Figure 65. Middle East & Africa: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 66. Middle East & Africa Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 67. South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 68. Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 69. UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 70. Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 71. Impact of COVID-19 Pandemic on North American Country Markets
• Figure 72. Impact of COVID-19 Pandemic on European Country Markets
• Figure 73. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
• Figure 74. Impact of COVID-19 Pandemic on South and Central America Country Markets
• Figure 75. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets
• Figure 76. Growth Strategies in Clinical Trial Imaging Market